Studies on the Pathogenesis of Avascular Retina and Neovascularization into the Vitreous in Peripheral Severe Retinopathy of Prematurity (An American Ophthalmological Society Thesi...

Por Hartnett, Mary Elizabeth
Publicado em 2010

ADVANCES IN UNDERSTANDING AND MANAGEMENT OF RETINOPATHY OF PREMATURITY

Por Hartnett, Mary Elizabeth
Publicado no Surv Ophthalmol (2016)

Mechanisms and Management of Retinopathy of Prematurity

Por Hartnett, Mary Elizabeth, Penn, John S.
Publicado em 2012

Successful management of post-traumatic vancomycin-resistant enterococcus endophthalmitis

Por Nguyen, Jason, Hartnett, Mary Elizabeth
Publicado no Am J Ophthalmol Case Rep (2017)

Genomics in the Neonatal Nursery: Focus on ROP

Por Hartnett, Mary Elizabeth, Cotten, C. Michael
Publicado no Semin Perinatol (2015)

The utility of ultra-widefield fluorescein angiography in pediatric retinal diseases

Por Calvo, Charles M., Hartnett, Mary Elizabeth
Publicado no Int J Retina Vitreous (2018)

Signaling Pathways Triggered by Oxidative Stress Mediate Features of Severe Retinopathy of Prematurity

Por Wang, Haibo, Zhang, Sarah X, Hartnett, Mary Elizabeth
Publicado em 2013

Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP

Por Budd, Steven, Byfield, Grace, Martiniuk, David, Geisen, Pete, Hartnett, Mary Elizabeth
Publicado em 2009

BMPER regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy

Por Moreno-Miralles, Isabel, Ren, Rongqin, Moser, Martin, Hartnett, Mary Elizabeth, Patterson, Cam
Publicado em 2011

The Predictive Value of Pre-plus Disease in Retinopathy of Prematurity

Por Wallace, David K., Freedman, Sharon F., Hartnett, Mary Elizabeth, Quinn, Graham E.
Publicado em 2011

Real-Time, Computer-Assisted Quantification of Plus Disease in Retinopathy of Prematurity at the Bedside

Por Cabrera, Michelle T., Freedman, Sharon F., Hartnett, Mary Elizabeth, Stinnett, Sandra S., Chen, Bei Bei, Wallace, David K.
Publicado no Ophthalmic Surg Lasers Imaging Retina (2014)

Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization

Por Bretz, Colin A., Divoky, Vladimir, Prchal, Josef, Kunz, Eric, Simmons, Aaron B., Wang, Haibo, Hartnett, Mary Elizabeth
Publicado no Sci Rep (2018)

Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10

Por Scott, Ingrid U., VanVeldhuisen, Paul C., Oden, Neal L., Ip, Michael S., Blodi, Barbara A., Hartnett, Mary Elizabeth, Cohen, Geoff
Publicado em 2011

Provider Use of Collaborative Goal Setting with Glaucoma Patients

Por Sleath, Betsy, Slota, Catherine, Blalock, Susan J., Sayner, Robyn, Carpenter, Delesha M., Muir, Kelly W., Hartnett, Mary Elizabeth, Robin, Alan L.
Publicado em 2014

Glaucoma Patient Expression of Medication Problems and Nonadherence

Por Slota, Catherine, Sayner, Robyn, Vitko, Michelle, Carpenter, Delesha M., Blalock, Susan J., Robin, Alan L., Muir, Kelly W., Hartnett, Mary Elizabeth, Sleath, Betsy
Publicado no Optom Vis Sci (2015)

Accuracy of patient-reported adherence to glaucoma medications on a visual analog scale as compared with electronic monitors

Por Sayner, Robyn, Carpenter, Delesha M., Blalock, Susan J., Robin, Alan L., Muir, Kelly W., Hartnett, Mary Elizabeth, Giangiacomo, Annette L., Tudor, Gail, Sleath, Betsy
Publicado no Clin Ther (2015)

Glaucoma patient-provider communication about vision quality-of-life

Por Sleath, Betsy, Sayner, Robyn, Vitko, Michelle, Carpenter, Delesha M., Blalock, Susan J., Muir, Kelly W., Giangiacomo, Annette L., Hartnett, Mary Elizabeth, Robin, Alan L.
Publicado no Patient Educ Couns (2016)

Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients

Por Carpenter, Delesha M., Tudor, Gail E., Sayner, Robyn, Muir, Kelly W., Robin, Alan L., Blalock, Susan J., Hartnett, Mary Elizabeth, Giangiacomo, Annette L., Sleath, Betsy L.
Publicado no Patient Educ Couns (2015)

Stanniocalcin-1 is a modifier of oxygen induced retinopathy severity

Por Dalvin, Lauren A., Hartnett, Mary Elizabeth, Bretz, Colin A., Hann, Cheryl R., Cui, Ricky Z, Marmorstein, Alan D., Sheikh-Hamad, David, Fautsch, Michael P., Roddy, Gavin W.
Publicado no Curr Eye Res (2019)

Provider Education about Glaucoma and Glaucoma Medications during Videotaped Medical Visits

Por Sleath, Betsy, Blalock, Susan J., Carpenter, Delesha M., Muir, Kelly W., Sayner, Robyn, Lawrence, Scott, Giangiacomo, Annette L., Hartnett, Mary Elizabeth, Tudor, Gail, Goldsmith, Jason, Robin, Alan L.
Publicado em 2014